IL15 and colorectal carcinoma: However, on a positive side, the impaired functionality of NK cells isolated from the peripheral blood of patients with CRC can be recovered by either IL-2 or IL-15 and when combined with Cetuximab enables antibody-dependent cellular cytotoxicity (ADCC) (61).